Health risk behaviors associated with lower prostate specific antigen awareness. Findings also suggest that less prostate cancer screening is likely.

Initiatives seek to raise prostate cancer awareness among black men and improve health outcomes.

Brachytherapy, also called seed implants, may be a more beneficial treatment than surgery or external beam radiation therapy for overweight or obese prostate cancer patients.

New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients.

Recently, PSA or prostate-specific antigen, screening made headlines when a US Preventive Task Force recommended that men over the age 75 discontinue screening for prostate cancer.

Analysis has shown that more men need to undergo prostate cancer screening tests, especially black males who are at higher risk.

One in five men in their 40s has had a prostate specific antigen (PSA) test within the previous year and that young black men are more likely than young white men to have undergone the test.

Men age 75 and older should not be screened for prostate cancer, and younger men should discuss the benefits and harms of the prostate-specific antigen (PSA) test with their clinicians before being tested.

Scientists report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they described as a "powerhouse" that drives runaway cell growth.